Patents by Inventor Hideki Hirose

Hideki Hirose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210115048
    Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.
    Type: Application
    Filed: April 26, 2018
    Publication date: April 22, 2021
    Inventors: Shuji KITAMURA, Zenichi IKEDA, Minoru IKOMA, Koji WATANABE, Hideki HIROSE, Takafumi YUKAWA, Sachie MORIMOTO, Naoki NISHIZAWA, Taiji ASAMI
  • Patent number: 10919891
    Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: February 16, 2021
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Shuji Kitamura, Zenichi Ikeda, Sachie Morimoto, Minoru Ikoma, Koji Watanabe, Hideki Hirose, Takafumi Yukawa, Kenjiro Sato
  • Patent number: 10875862
    Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: December 29, 2020
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Shuji Kitamura, Zenichi Ikeda, Sachie Morimoto, Minoru Ikoma, Koji Watanabe, Hideki Hirose, Takafumi Yukawa, Kenjiro Sato
  • Publication number: 20200131174
    Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.
    Type: Application
    Filed: April 26, 2018
    Publication date: April 30, 2020
    Inventors: Shuji KITAMURA, Zenichi IKEDA, Sachie MORIMOTO, Minoru IKOMA, Koji WATANABE, Hideki HIROSE, Takafumi YUKAWA, Kenjiro SATO
  • Patent number: 9751878
    Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: September 5, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina, Yoichi Nishikawa
  • Patent number: 9605000
    Abstract: Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: March 28, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo Kasai, Masaki Ogino, Ryo Mizojiri, Takeshi Yamasaki, Hideki Hirose, Nobuyuki Takakura, Tohru Yamashita, Sachie Morimoto, Takashi Nakahata, Asato Kina
  • Publication number: 20160237087
    Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.
    Type: Application
    Filed: April 27, 2016
    Publication date: August 18, 2016
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina, Yoichi Nishikawa
  • Patent number: 9353108
    Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: May 31, 2016
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina
  • Patent number: 9288354
    Abstract: An image forming apparatus is provided that is capable of returning from a sleep state in response to detection of a user or upon receipt of an input, wherein notification of failure to detect a user is provided if the image forming apparatus returns from a sleep state based on receipt of an input for more than a predetermined number of times.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: March 15, 2016
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Hideki Hirose
  • Publication number: 20160060273
    Abstract: Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.
    Type: Application
    Filed: March 13, 2014
    Publication date: March 3, 2016
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo KASAI, Masaki OGINO, Ryo MIZOJIRI, Takeshi YAMASAKI, Hideki HIROSE, Nobuyuki TAKAKURA, Tohru YAMASHITA, Sachie MORIMOTO, Takashi NAKAHATA, Asato KINA
  • Patent number: 9133129
    Abstract: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: September 15, 2015
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Tohru Yamashita, Takuya Fujimoto, Ryo Mizojiri, Kazuko Yonemori, Hideki Hirose, Zenichi Ikeda, Ikuo Fujimori, Kyoko Toyofuku, Tsuneo Yasuma, Nobuyuki Matsunaga
  • Patent number: 9120777
    Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent the prophylaxis or treatment of diabetes mellitus are provided.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: September 1, 2015
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo Kasai, Asato Kina, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Yoichi Nishikawa
  • Publication number: 20150119412
    Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent the prophylaxis or treatment of diabetes mellitus are provided.
    Type: Application
    Filed: October 28, 2014
    Publication date: April 30, 2015
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo Kasai, Takashi Nakahata, Asato Kina, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Yoichi Nishikawa
  • Publication number: 20150099777
    Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.
    Type: Application
    Filed: October 3, 2014
    Publication date: April 9, 2015
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina, Yoichi Nishikawa
  • Publication number: 20140243310
    Abstract: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Application
    Filed: October 23, 2012
    Publication date: August 28, 2014
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Tohru Yamashita, Takuya Fujimoto, Ryo Mizojiri, Kazuko Yonemori, Hideki Hirose, Zenichi Ikeda, Ikuo Fujimori, Kyoko Toyofuku, Tsuneo Yasuma, Nobuyuki Matsunaga
  • Patent number: 8703758
    Abstract: The present invention provides to a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer and the like, and has superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: April 22, 2014
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Tohru Yamashita, Makoto Kamata, Hideki Hirose, Masataka Murakami, Takuya Fujimoto, Zenichi Ikeda, Tsuneo Yasuma, Ikuo Fujimori, Ryo Mizojiri, Tomoya Yukawa
  • Patent number: 8681371
    Abstract: An image forming apparatus including a formation unit for forming patch images for calibration of an output image, a detection unit disposed on a paper conveyance path and configured to detect the fixed patch images formed on paper by the formation unit, and a correction unit for performing the calibration using the patch images detected by the detection unit is provided. When the formation unit forms the patch images, the formation unit arranges the images on both sides of a medium. On the front surface of the medium, a low-density patch image is formed, and on the back surface of the medium, a high-density patch image is formed. Alternatively, a media on which the patch image is formed is discharged once, and a user turns the medium upside down and feeds the medium again such that the first and second patch image formation positions differ from each other.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: March 25, 2014
    Assignee: Canon Kabushiki Kaisha
    Inventor: Hideki Hirose
  • Publication number: 20140063528
    Abstract: An image forming apparatus is provided that is capable of returning from a sleep state in response to detection of a user or upon receipt of an input, wherein notification of failure to detect a user is provided if the image forming apparatus returns from a sleep state based on receipt of an input for more than a predetermined number of times.
    Type: Application
    Filed: September 4, 2013
    Publication date: March 6, 2014
    Inventor: Hideki Hirose
  • Patent number: 8610912
    Abstract: An image processing apparatus displays a screen for designating cooperative processing in which the image processing apparatus and at least one other image processing apparatus cooperate based on externally received information, where if an execution instruction for processing to be executed by the image processing apparatus for the cooperative processing is received, the processing is executed. A screen displaying the status of processing in the at least one other image processing apparatus and a screen enabling designation of subsequent processing to be executed by the image processing apparatus are displayed based on the externally received screen information while the at least one other image processing apparatus is executing processing to be executed by the at least one other image processing apparatus for the cooperative processing after the execution of the processing.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: December 17, 2013
    Assignee: Canon Kabushiki Kaisha
    Inventor: Hideki Hirose
  • Patent number: 8467074
    Abstract: A method for controlling an apparatus, including a plurality of lockable discharge units configured to discharge a printed product having an image formed thereon based on a received job to any one of the plurality of lockable discharge units, includes managing information about a lockable discharge unit to which the printed product is discharged in association with information about a user, notifying the user to prompt picking up the printed product discharged to the lockable discharge unit based on the managed information, and determining whether a particular user is using the plurality of lockable discharge units based on the managed information, wherein, in a case where the particular user is using the plurality of lockable discharge units, the notification is performed.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: June 18, 2013
    Assignee: Canon Kabushiki Kaisha
    Inventor: Hideki Hirose